NewsMore 
August 7, 2007; CHINDEX INTERNATIONAL ANNOUNCES DA VINCI® S" SYSTEM CONTRACT IN HONG KONG; Queen Mary Hospital will be Chindexs Fourth Intuitive Surgical Installation in Greater China
August 3, 2007; CHINDEX INTERNATIONAL, INC. SIGNS CONTRACT FOR FIRST EXIM-SPONSORED MEDICAL EQUIPMENT SALE IN CHINA UNDER NEW EXIM-MOF FRAMEWORK
     
   
  Home » News » Press Release
 
CHINDEX INTERNATIONAL, INC.
Announces Change in Fiscal Year

BETHESDA, MARYLAND (March 31, 2003) . . . Chindex International, Inc. (NASDAQ: CHDX), the leading independent American company providing Western healthcare products distribution and medical services in the People's Republic of China, today announced that its Board of Directors has approved a resolution changing the company's fiscal year from December 31 to March 31. The change was effective as of March 31, 2003.

"Chindex has decided to change its fiscal year from December 31 to March 31 for two primary reasons," Roberta Lipson, President and CEO noted. "The first being to better align our financial year reporting with the annual purchasing cycles for medical equipment in the Chinese marketplace. Secondly, by moving off the calendar year cycle we expect to be able to better contain our annual audit related expenses on a global basis. We do not expect this change to have a large impact on our year to year results."

The Company has today filed a report on Form 8K announcing the change and expects to file its transition report for the three months ended March 31, 2003 on Form 10K on or about June 30, 2003. The Company also announced it will harmonize its U.S. tax year with the March 31 fiscal year.

Chindex is a leading American company in healthcare in the Greater Chinese marketplace including Hong Kong. It provides representative and distribution services to a number of major multinational companies including Siemens AG (diagnostic color ultrasound scanners under the Acuson and Siemens brand names), Becton-Dickinson (including vascular access, infusion and critical care systems), Johnson & Johnson (clinical chemistry analyzers), and Guidant (interventional cardiology products including stents, balloon catheters, and guide wires). It also provides healthcare services through the operations of its private hospital corporation in China. With more than twenty years of experience, over 600 employees, and operations in the United States, China and Hong Kong, the Chindex strategy is to expand its cross-cultural reach by providing leading edge technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Chindex website, www.chindex.com and www.unitedfamilyhospitals.com.

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties pertaining to the Company's (i) performance goals, including successful conclusion of efforts to secure government-backed financing, (ii) future events and earnings, including revenues from the Company's developmental businesses such as healthcare services, (iii) markets, including growth in demand in China for the Company's products and services, and (iv) proposed new operations, including expansion of its healthcare services business. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


Copyright © 2002 Chindex International, Inc. All Rights Reserved